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doi:10.1016/j.ejvs.2008.06.008Abstract Objective: Recent meta-analyses confirm an advantage to patch angioplasty during
carotid endarterectomy (CEA) and suggest a benefit from routine shunting. GALA Trial (RCT:
general [GA] versus local [LA] anaesthesia for CEA) collaborators (non-UK [European] and
UK) were surveyed to assess current practice techniques.
Materials and Methods: Postal questionnaires determined: shunt usage, monitoring techniques
dictating shunt deployment, criteria for patching and the influence of anaesthetic technique
upon these decisions.
Results: 157/216 surgeons (73%) replied. For UK surgeons (nZ 76) performing GA CEA a shunt
was always, never, or selectively used by 73.6%, 4.2% and 22.2% respectively. Figures for
non-UK surgeons (nZ 77) were 20.8% (p< 0.0001), 26% (p< 0.0002) and 53.2% (p< 0.0001).
When shunting selectively, fewer UK surgeons relied on stump pressure (26.4% v 48.1%;
p< 0.0064) with TCD more widely used (38.9% v 11.7%; p< 0.0001). Shunting criteria during
LA CEA were the same for both groups (impaired awake-testing). Routine patching was
commoner amongst UK surgeons (GA: 76.4% v 34.2%, p < 0.0001; LA: 70.1% v 31.9%,
p< 0.0001).
Conclusions: These results indicate that more UK surgeons have adopted current suggestions
for improving CEA outcomes. Future analysis of unblinded GALA Trial data may provide further
information about the impact of different policies for shunting and patching.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.h, Consultant Vascular Sur-
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ty for Vascular Surgery. PublisheIntroduction
Carotid endarterectomy (CEA) has a proven benefit in
preventing future ipsilateral stroke in patients with
a >50% symptomatic internal carotid artery (ICA) stenosis.1
Despite this there is considerable heterogeneity in the
surgical techniques used to achieve this objective, andd by Elsevier Ltd. All rights reserved.
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Fig. 1 Differences between UK and Non-UK European sur-
geons for shunt (GA CEA: Always p< 0.0001; never p< 0.0001;
selective p< 0.0002) and patch during CEA (p< 0.0001 for rou-
tine use).
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mortality and long-term durability remain undetermined.
Some of the issues that are unresolved include the
indication for shunt utilisation, the choice technique for
assessing the adequacy of intra-operative cerebral perfu-
sion, use of a patch for arteriotomy closure and the type
of patch material that minimises early ICA occlusion and
long-term re-stenosis.
Finally it has been suggested that the method of anaes-
thesia might influence outcome. Whilst local anaesthesia
was preferred by many early carotid surgeons a shift to
general anaesthesia (GA) followed the report byWells et al.2
which suggested GA may promote cerebral protection.
These views have been challenged by studies that suggest
preservation of cerebral auto-regulation and sympathetic
drive during local anaesthesia (LA)3,4 and these controver-
sies were discussed in a review by McCleary et al.5 Further,
although data from non-randomised, studies suggest a bene-
fit to LA CEA (reduction in stroke, MI and death rates) there is
insufficient evidence currently to dictate a change in
practise regarding the type of anaesthesia. Analysis of the
data from the GALA Trial may resolve this issue.
At the time of survey trial collaborators comprised 216
surgeons in 71 centres and this cohort has provided a unique
opportunity to identify the technical practises currently
employed by surgeons throughout Europe.
These aspects of CEA in the UK have been assessed
previously by Murie et al.6e8 in 1989, 1991 and 1994. These
serve as basis for comparison with current data.
This study reports the results from a questionnaire based
on a survey of the surgeons participating in the GALA trial.
Furthermore technical practices regarding CEA in the UK
and Europe have also been compared with the practises
followed by the participants in the European Carotid
Surgery Trial (ECST).
Method
Postal questionnaires determined: shunt usage, monitoring
techniques dictating shunt deployment, patch use, patch-
ing criteria, and the influence of anaesthetic technique
(GA/LA) upon these decisions amongst surgeons participat-
ing in the GALA trial. The Trial protocol stated that a shunt
should only be used during local anaesthetic surgery when
indicated by awake testing. For all other technical aspects
of surgery Trial participants were advised to continue their
normal practice. The results were analysed using SPSS
statistical software.
Results
Questionnaires were sent to 216 surgeons in 71 centres in
Europe (non-UK) and UK. 157 questionnaires (73%) were
returned from 68 (96%) centres (Europe e 77; UK e 76).
Shunt utilisation
On cumulative analysis 47% of the surgeons always use
a shunt when performing a GA CEA as compared to 1% under
LA. Only 50% of the surgeons used a shunt selectively during
GACEA as compared to LA surgery (37% vs. 73%). The practiseof the surgeons who rarely or never use a shunt (GA: 15%; LA:
16%) was not influenced by the type of anaesthetic.
Comparative analysis of shunt utilisation under GA
(Fig. 1) showed that 73.6% of UK surgeons always used
a shunt as compared to 20.8% in rest of Europe
(p< 0.0001). Selective shunting with intraoperative moni-
toring of a marker of cerebral perfusion was less common
in the UK (22.2%) as compared to Non-UK European
surgeons (53.2%; p< 0.0001). 4.2% of the UK surgeons never
used a shunt under GA compared to 26% in Non-UK Europe
(p< 0.0002).
Intra-operative monitoring
There was a wide diversity in the methods used for
monitoring intra-operative cerebral perfusion when a policy
of selective shunting was used during GA surgery. Carotid
stump pressure measurements were used most often (37%),
followed by transcranial doppler (TCD, 25%). Electroen-
cephalography (EEG) was utilised by 10% of the surgeons
and somatosensory evoked potential (SSEP) and near-
infrared spectroscopy by 5% each. Of the remaining 27
surgeons (18%) 25 did not use any form of monitoring during
GA CEA (3 UK, 22 non-UK) and 2 non-UK surgeons used
another unspecified monitoring technique. Of the 25
surgeons who performed no monitoring 13 never or rarely
used a shunt during GA surgery whilst the remainder did so
in the presence of contra lateral disease or poor back flow
from the ICA.
There were significant variations in this practice be-
tween the UK and Non-UK European surgeons (Fig. 2), with
TCD being the most common modality employed in the UK
(38.9%) as compared to stump pressure in the rest of Europe
(48.1%). EEG and SSEP were also more commonly used in
Europe (32.5% v 4.2%; p< 0.0001).
Patch angioplasty
Routine patch angioplasty was significantly more common
in the UK (76%) compared to the rest of Europe (34%;
p< 0.0001). Further 52.6% of the Non-UK surgeons practise
Fig. 2 Intraoperative monitoring techniques for markers of
cerebral perfusion during GA CEA (UK versus rest of Europe:
TCD p< 0.0001; stump pressure p< 0.006; EEG/SSEP
p< 0.0001).
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(Fig. 1). A small artery was the most common reason for
selective patching although only 8% of the surgeons used
objective arterial diameter measurement prior to decide
this. Other reasons for selective patching included: female
sex, re-stenosis after previous CEA (ipsilateral or contralat-
eral), shunt use and a tortuous ICA. Finally 13.2% of the
Non-UK European surgeons and 4.2% of the UK surgeons
never use a patch irrespective of the ICA size or the type
of anaesthetic used.
Dacron was the most commonly used patch material by
all surgeons (UK 82%; Non-UK European 60%), followed by
Polutetrafluoroethylene (PTFE) and vein. Both PTFE and
vein patch were used more commonly in Non-UK Europe
(Fig. 3).
Discussion
The results have been compared to those from a previous
UK surveys by Murie et al. in 1986, 1991 and 1994.6e8 In the
previous UK survey (1994)8 obligatory shunting (35%) and
patching (21%) were less frequent (p< 0.0001) with low
stump pressure being the main criterion for shunting (41% v
26.4%; p< 0.0001).Fig. 3 Patch angioplasty trends in UK for CEA.A slight alteration in the survey questions makes direct
comparison of these studies difficult but overall there was
an increased utilisation of patches to cover the arteriotomy
site, with vein patches being the most popular. Similarly
a significant increase in routine and selective utilisation of
intra-operative shunts was seen, particularly compared to
the 1989 survey.7 Stump pressure measurement was the
most commonly used parameter to dictate shunt deploy-
ment in these studies with virtually all CEAs being done
under GA, particularly in the first two surveys.
Although there is strong evidence to support the routine
patch angioplasty9 during CEA there is insufficient evidence
from previous meta-analyses of randomised control trials to
give clear guidance in respect of the type of patch or the
routine use of a shunt.10 The data presented in this study
reflects current variation in technical practice in Non-UK
Europe and UK. Further, it allows comparison with the
data from ECST11 to identify changes in practice.
Although not the focus of the current study it is
interesting to note that only one UK surgeon was using LA
in the 1986 UK survey6 and 2e5 surgeons in subsequent sur-
veys in 1991 and 1994.7,8 Similarly only 3.4% of operations
were preformed under LA in the ECST trial.11 The wide-
spread use of GA is reflected by the controversy over the
use of a shunt and the selection of the most appropriate
modality for identifying patients who will benefit from
this when a strategy of selective shunting is adopted.
Thus, there is a considerable variation in shunt utilisation
during CEA with some surgeons shunting all patients and
others never using a shunt because of the potential risk of
neurological complications through platelet and air emboli,
intimal damage, late re-stenosis and arterial dissection.
Compared to previous data there has been a significant
increase (p< 0.0001) in obligatory shunting by UK surgeons
from 33% and 38% in previous surveys,6,7 and 45% in ECST11
to 73% in the current study. Conversely routine shunting by
Non-UK European surgeons has remained low at 30% in ECST
and 20% in GALA. Not surprisingly, selective shunting is
more prevalent amongst Non-UK Europeans (53%) compared
to UK surgeons (22.2%) whilst only 4.2% of the latter never
use a shunt compared to 26% of the former when perform-
ing GA CEA.
In a review by Bond et al.12 in 2002 the authors
concluded that there was insufficient evidence to support
either routine or selective shunting during CEA although
available data suggested that a combination of EEG moni-
toring and carotid pressure assessment may reduce the
number of shunts used under GA. This difficulty in identify-
ing a reliable method of selecting patients for shunting is
a major attraction to performing LA CEA with shunt deploy-
ment decided upon the results of awake testing.
Although the concept of selective shunting is logical, the
inadequacy (false positive and false negative results) of
current techniques to identify appropriate patients, and the
differential impact of anaesthetic type upon cerebral autor-
egulation make this difficult. Thus both EEG and carotid
stump pressures may be normal in 6-30% of patients who
subsequently develop neurological signs and abnormal in
3-11% of those who do not develop signs of ischaemia.13,14
Traditionally stump pressure measurement was the most
common monitoring method used for selective shunting in
the UK. In the present survey this remains the case for all
388 H.R.S. Girn et al.surgeons participating in the GALA trial (37%) followed by
TCD at 25%. However TCD was the most common mode of
intra-operative monitoring used for selective shunting by
UK surgeons (38.9%) compared to stump pressure in Non-UK
European surgeons (48.1%). EEG has become less popular
amongst UK surgeons with 23% using this in the ECST trial
but only 4.2% in the GALA trial.
The benefits of patching continue to be debated.
Although conclusive evidence could not be drawn in the
2004 Cochrane review,10 the report appeared to recom-
mend routine patching to reduce early ICA occlusion
and late re-stenosis. Thus patching was also associated
with a reduction in the risk of stroke or death rates (OR
0.59, 95% CI 0.42 to 0.84, pZ 0.004), equivalent to about
75 fewer deaths or strokes per 1000 patients who
received a patch. Although the review was considered
inconclusive due to methodological flaws in the original
trials patch utilisation in the UK has undoubtedly
increased over the last 2 decades (Fig. 3). Thus, in 1986
only 2% of UK surgeons always used a patch compared
to 21% in the ECST trial10 and 27% in the Murie’s 1994 sur-
vey.7 Although patch use was more prevalent amongst
Non-UK European surgeons (32%) in ECST data from the
current study shows that there has been no real change
since then (34%) whilst 76% of UK collaborators now patch
routinely.
Bond et al. also reviewed 8 trials (1480 operations) to
estimate the impact of patch-type on early and late
outcomes after CEA.15 Although the synthetic patches
were associated with reduced morbidity and operative
time associated with a vein harvest, there was no conclu-
sive evidence to support a particular type of patch in
improving outcomes. In a later study by Verhoeven
et al.,16 who reviewed 319 patients undergoing CEA (26%
primary closures, 53.6% vein patches and 20.4% Dacron
patches), re-stenosis rate was more common after Dacron
patching or primary closure. That these differences were
more profound in the females was explained on the basis
of their smaller calibre vessels.
Although vein patches harvested from the ankle were
initially popular in the UK reports of postoperative patch
rupture and increasing use of LA CEA has lead to the
predominant use of synthetic patches. Previous reports
suggest that PTFE was more widely used previously but data
from the GALA trial shows that Dacron is now the most
commonly utilised material in both Europe and UK although
a proportion of Non-UK European surgeons are more likely
to use a vein or a PTFE patch (Fig. 1).
In conclusion this report highlights a wide variation in
the use of patches and shunts across Europe. This could be
a potential source of heterogeneity in the data from the
GALA trial and multivariate analysis of the impact of
perioperative processes of care will be necessary in the
final analysis of the trial results. Nevertheless, these vari-
ables did not influence the results of ECST trial and unless
data to the contrary is provided by GALA trial,surgeons
should continue their ‘usual’ surgical practice.1 Centres included as Non-UK centres for the purpose of this
survey.Ethical approval
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